Literature DB >> 26067706

Treatment of Secondary Osteonecrosis of the Knee With Local Debridement and Osteoprogenitor Cell Grafting.

Stuart B Goodman1, Katherine L Hwang1.   

Abstract

Secondary osteonecrosis of the knee (SOK) affects young individuals with chronic diseases and corticosteroid use. We report a series of young patients in whom the osteonecrotic lesion was openly debrided, and concentrated bone marrow osteoprogenitor cells (OPCs) harvested from the iliac crest were placed in the defect. Twelve patients (fourteen knees) have undergone debridement and grafting of distal femoral osteonecrotic lesions. Age at surgery averaged 23 years. Follow-up averaged 5 years. None of the patients have undergone further surgery, or were taking medications for ipsilateral knee pain. Knee Society Score and Knee Function Score averaged 87 and 85 respectively. The technique of open debridement and osteoprogenitor cell grafting for SOK is relatively simple, efficacious, has low morbidity, and does not preclude future interventions.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  avascular necrosis; femur; knee; osteonecrosis; osteoprogenitor cell grafting

Mesh:

Substances:

Year:  2015        PMID: 26067706     DOI: 10.1016/j.arth.2015.05.013

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  11 in total

Review 1.  The biological basis for concentrated iliac crest aspirate to enhance core decompression in the treatment of osteonecrosis.

Authors:  Stuart B Goodman
Journal:  Int Orthop       Date:  2018-02-12       Impact factor: 3.075

2.  Osteogenic ability of rat bone marrow concentrate is at least as efficacious as mesenchymal stem cells in vitro.

Authors:  Yusuke Kohno; Tzuhua Lin; Jukka Pajarinen; Monica Romero-Lopez; Masahiro Maruyama; Jhih-Fong Huang; Karthik Nathan; Zhenyu Yao; Stuart B Goodman
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2019-02-19       Impact factor: 3.368

Review 3.  Mesenchymal stem cell-macrophage crosstalk and bone healing.

Authors:  Jukka Pajarinen; Tzuhua Lin; Emmanuel Gibon; Yusuke Kohno; Masahiro Maruyama; Karthik Nathan; Laura Lu; Zhenyu Yao; Stuart B Goodman
Journal:  Biomaterials       Date:  2018-01-02       Impact factor: 12.479

Review 4.  Stem Cell Considerations for the Clinician.

Authors:  Karen A Hasty; Hongsik Cho
Journal:  Phys Med Rehabil Clin N Am       Date:  2016-11       Impact factor: 1.784

5.  Treatment options for secondary osteonecrosis of the knee.

Authors:  Hassan Zmerly; Manuela Moscato; Ibrahim Akkawi; Riccardo Galletti; Valentina Di Gregori
Journal:  Orthop Rev (Pavia)       Date:  2022-04-25

6.  Use of autologous bone marrow stem cell implantation for osteonecrosis of the knee in sickle cell disease: a preliminary report.

Authors:  Gildasio Daltro; Bruno Adelmo Franco; Thiago Batista Faleiro; Davi Araujo Veiga Rosário; Paula Braga Daltro; Roberto Meyer; Vitor Fortuna
Journal:  BMC Musculoskelet Disord       Date:  2018-05-22       Impact factor: 2.362

7.  Femoral condylar necrosis: treatment with hyperbaric oxygen therapy.

Authors:  Gerardo Bosco; Giuliano Vezzani; Garrett Enten; Daniele Manelli; Nisha Rao; Enrico M Camporesi
Journal:  Arthroplast Today       Date:  2018-09-01

8.  Intraosseous Bioplasty for a Chondral Cyst in the Lateral Tibial Plateau.

Authors:  Nicholas Elena; Brittany M Woodall; Katie Lee; Patrick J McGahan; Neil P Pathare; Edward C Shin; James L Chen
Journal:  Arthrosc Tech       Date:  2018-10-15

Review 9.  Aging, inflammation, stem cells, and bone healing.

Authors:  Emmanuel Gibon; Laura Lu; Stuart B Goodman
Journal:  Stem Cell Res Ther       Date:  2016-03-22       Impact factor: 6.832

10.  Osteochondral allograft in a patient with avascular necrosis of the knee secondary to lupus.

Authors:  Fernando Fonseca
Journal:  Rev Bras Ortop       Date:  2018-09-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.